Since CCK-2R is overexpressed on medullary thyroid carcinoma cells (MTC), targeting peptides are useful as a vector for diagnostic imaging and targeted radionuclide therapy (TRNT) of MTC. Here, CCKBR is linked to medullary thyroid gland carcinoma.